Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development? (Q37976121)

From Wikidata
Jump to navigation Jump to search
scientific article published on 17 January 2012
edit
Language Label Description Also known as
English
Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development?
scientific article published on 17 January 2012

    Statements

    Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development? (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit